[Study on safety and effect of purified inactivited Japanese encephalitis vaccine (primary hamster kidney cell, PHK)].
In order to observe the safety and neutralizing antibody response to purified inactivated Japanese encephalitis vaccine (primary hamster kidney cell, PHK). Phase I, II, III field trials were performed and 943 healthy volunteers aged from 6 months to 10 years were administrated the JEV-I (PHK) vaccine at day 0 and day 7 respectively. The vaccine did not cause any severe systemic and local adverse reactions. In phase I, 40 healthy volunteers were inoculated and the total reaction rate was 2.5%. In phase II and III, 903 healthy volunteers were inoculated JEV-I (PHK) and 101 healthy volunteers were inoculated with the Vero cell-derived JEV vaccine, the total adverse reaction rates were 6.2% and 14.2% respectively. The positive sero conversion rates of neutralizing antibody to the test and the control vaccine in antibody negative group were 96.9% (Geometric Mean Titers, GMT1:32.8) and 84.0% (GMT1:43.9) respectively and in antibody positive group were 93.1% (GMT1:167.2) and 100% (GMT1:181.0) respectively. The JEV-I (PHK) vaccine is safe and effective. Trial Registration National Food drugs surveillance administrative bureau, "Medicine Clinical Experiment Written Directive from a Superior" number: 2003L00429.